MAMMALIAN PHENOTYPE - ANNOTATIONS
The Mouse Adult Gross Anatomy Ontology and Mammalian Phenotype Ontology are downloaded weekly from the Mouse Genome Informatics databases at Jackson Laboratories (ftp://ftp.informatics.jax.org/pub/reports/index.html). For more information about these ontologies, see the MGI Publications Page at http://www.informatics.jax.org/mgihome/other/publications.shtml.
Term: abnormal triglyceride level
Accession: MP:0000187
browse the term
Definition: any anomaly in the concentration of triglyceride, a glycerol esterified at each of its three hydroxyl groups by a fatty acid; triglyceride is an important molecule for storage of fatty acids in adipose tissue
Synonyms: exact_synonym: abnormal triacylglycerol level
alt_id: MP:0001551
G
Angptl8
angiopoietin-like 8
induces
IMP
compared to wild type rats
RGD
PMID:30042156 PMID:30042156
RGD:38549347 , RGD:38549347
NCBI chr 8:28,652,555...28,654,581
Ensembl chr 8:20,376,462...20,378,490
G
Angptl8em1Kyo
angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo
induces
IMP
compared to wild type rats
RGD
PMID:30042156 PMID:30042156
RGD:38549347 , RGD:38549347
G
Dpp4
dipeptidylpeptidase 4
IAGP
compared to DA/Ztm
RGD
PMID:19327106
RGD:41408336
NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:46,962,243...47,043,901
G
Dpp4DPPIV
dipeptidylpeptidase 4; DPPIV mutant
IAGP
compared to DA/Ztm
RGD
PMID:19327106
RGD:41408336
G
Htr7
5-hydroxytryptamine receptor 7
IMP
in male
RGD
PMID:31125290
RGD:14696717
NCBI chr 1:243,049,064...243,173,636
Ensembl chr 1:233,636,452...233,760,626
G
Htr7em1Msu
5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu
IMP
in male
RGD
PMID:31125290
RGD:14696717
G
Lrrk2
leucine-rich repeat kinase 2
IMP
RGD
PMID:23799078
RGD:13462048
NCBI chr 7:124,706,246...124,867,234
Ensembl chr 7:122,826,696...122,987,703
G
Lrrk2em1Sage
leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs
IMP
RGD
PMID:23799078
RGD:13462048
G
Zbtb16
zinc finger and BTB domain containing 16
IMP
compared to wild type SHR/OlaIpcv;
RGD
PMID:28396530
RGD:150340623
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:48,994,566...49,177,011
G
Zbtb16em1Ipcv
zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv
IMP
compared to wild type SHR/OlaIpcv;
RGD
PMID:28396530
RGD:150340623
G
Angptl8
angiopoietin-like 8
IMP
compared to wild type rats
RGD
PMID:30042156
RGD:38549347
NCBI chr 8:28,652,555...28,654,581
Ensembl chr 8:20,376,462...20,378,490
G
Angptl8em1Kyo
angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo
IMP
compared to wild type rats
RGD
PMID:30042156
RGD:38549347
G
Zbtb16
zinc finger and BTB domain containing 16
IMP
compared to wild type SHR/OlaIpcv;
RGD
PMID:28396530
RGD:150340623
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:48,994,566...49,177,011
G
Zbtb16em1Ipcv
zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv
IMP
compared to wild type SHR/OlaIpcv;
RGD
PMID:28396530
RGD:150340623
G
Cfb
complement factor B
IMP
compared to wild type SHR
RGD
PMID:28739975
RGD:127285403
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,951,474...3,976,505
G
Cfbem1Tja
complement factor B, ZFN induced mutant 1, Tja
IMP
compared to wild type SHR
RGD
PMID:28739975
RGD:127285403
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
IMP
RGD
PMID:25934999
RGD:11085488
NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:205,733,872...205,743,421
G
Bscl2m1Kyo
BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo
IMP
RGD
PMID:25934999
RGD:11085488
G
Gck
glucokinase
IDA
overexpression sufficient to lower blood glucose significantly increased circulating FFA and TG levels (p<0.05)
RGD
PMID:10512368
RGD:2301945
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:80,785,060...80,826,995
G
Gja8
gap junction protein, alpha 8
IAGP
RGD
PMID:27871290
RGD:150429989
NCBI chr 2:187,179,668...187,181,284
Ensembl chr 2:184,490,840...184,492,456
G
Gja8m1Cub
gap junction protein, alpha 8; mutant 1 Cub
IAGP
RGD
PMID:27871290
RGD:150429989
G
Lep
leptin
IMP
DNA:nonsense mutation:cds:
RGD
PMID:23800849
RGD:8549777
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Lepm1Kyo
leptin; ENU induced mutant1, Kyo
IMP
RGD
PMID:23800849
RGD:8549777
G
Lepr
leptin receptor
treatment disease_progression
IMP IAGP
compared to ad lib fed rats
RGD
PMID:27225180 PMID:11500530 PMID:27465994 PMID:26537785
RGD:12910507 , RGD:628581 , RGD:12911217 , RGD:12911216
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908
G
Leprem2Mcwi
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin
disease_progression
IMP
RGD
PMID:27465994
RGD:12911217
G
Leprem3
leptin receptor; TALEN induced mutant 3
IMP
RGD
PMID:27225180
RGD:12910507
G
Leprem4Lizh
leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh
IMP
compared to wild type littermate
RGD
PMID:26537785
RGD:12911216
G
Leprfa
leptin receptor; fa mutant
treatment
IAGP
compared to ad lib fed rats
RGD
PMID:11500530
RGD:628581
G
Mc4r
melanocortin 4 receptor
IMP
RGD
PMID:24400148
RGD:13825242
NCBI chr18:62,689,798...62,691,685
Ensembl chr18:60,419,832...60,421,719
G
Mc4rm1Hubr
melanocortin 4 receptor; ENU induced mutation 1, Hubr
IMP
RGD
PMID:24400148
RGD:13825242
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
IMP
compared to FHH
RGD
PMID:24722447
RGD:12910103
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:132,374,840...132,389,297
G
Nr4a1m1Mcwi
nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin
IMP
compared to FHH
RGD
PMID:24722447
RGD:12910103
G
Atp7b
ATPase copper transporting beta
IAGP
RGD
PMID:17303181
RGD:2292672
NCBI chr16:76,654,725...76,726,092
Ensembl chr16:69,951,778...70,023,636
G
Atp7bhts
ATPase copper transporting beta; hepatitis
IAGP
RGD
PMID:17303181
RGD:2292672
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
IMP
RGD
PMID:25934999
RGD:11085488
NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:205,733,872...205,743,421
G
Bscl2m1Kyo
BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo
IMP
RGD
PMID:25934999
RGD:11085488
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
induces
IMP
compared to wild type
RGD
PMID:29656108
RGD:150520032
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:111,178,703...111,244,794
G
Cyp2j4em1Sage
cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage
induces
IMP
compared to wild type
RGD
PMID:29656108
RGD:150520032
G
Ldlr
low density lipoprotein receptor
IMP
RGD
PMID:28469073
RGD:12910100
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Ldlrem1Sage
low density lipoprotein receptor; ZFN induced mutant 1, Sage
IMP
RGD
PMID:28469073
RGD:12910100
G
Lep
leptin
IMP
DNA:nonsense mutation:cds:
RGD
PMID:23800849
RGD:8549777
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Lepm1Kyo
leptin; ENU induced mutant1, Kyo
IMP
RGD
PMID:23800849
RGD:8549777
G
Pparg
peroxisome proliferator-activated receptor gamma
IAGP
RGD
PMID:27381370
RGD:127285618
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppargm1Kyo
peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo
IAGP
RGD
PMID:27381370
RGD:127285618
G
Lepr
leptin receptor
IAGP
DNA:mutations:cds: : (rat)
RGD
PMID:30278832 PMID:10901178 PMID:28746409
RGD:401960095 , RGD:401965414 , RGD:401965413
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:116,289,823...116,475,908
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all